OR WAIT null SECS
Click here to read the articles and download the PDF
Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.
A crash course on the bubble itself, including therapeutic areas most affected.
Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.
September 04, 2024
The project features several enhancements, including a new 67,000 square-foot warehouse at its HQ.
The latest news for pharma industry insiders.
September 03, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar.
How can industry stakeholders ensure the quality and supply chain security of existing product?
September 02, 2024
The 8,000 square-foot facility—located within the wholesaler’s Le Vergne distribution center— is expected to help tackle cell and gene therapy logistical challenges.
August 30, 2024
The company also participated in the coalition’s pilot inspection program, making it the first CDMO to do so.
The 3PL plans to convert all its trucks to electric by 2027.
August 29, 2024
Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.